We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.09%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.48B
AUM Growth
-$164M
Cap. Flow
-$190M
Cap. Flow %
-12.81%
Top 10 Hldgs %
34.21%
Holding
4,786
New
885
Increased
1,268
Reduced
1,496
Closed
1,028

Sector Composition

Rank Sector Weight
1 Industrials 5.52%
2 Technology 4.31%
3 Healthcare 3.85%
4 Consumer Discretionary 3.73%
5 Financials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KEQU icon
3276
Kewaunee Scientific
KEQU
$106M
$2K ﹤0.01%
88
+23
+35% +$494
KMX icon
3277
CarMax
KMX
$8.26B
$2K ﹤0.01%
24
-8,147
-100% -$637K
LBRDA icon
3278
Liberty Broadband Class A
LBRDA
$5.16B
$2K ﹤0.01%
22
-265
-92% -$26K
LBRDK icon
3279
Liberty Broadband Class C
LBRDK
$5.15B
$2K ﹤0.01%
19
-43
-69% -$4.24K
LINC icon
3280
Lincoln Educational Services
LINC
$1.3B
$2K ﹤0.01%
689
+534
+345% +$1.53K
LIT icon
3281
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$2K ﹤0.01%
71
-408
-85% -$11K
LPG icon
3282
Dorian LPG
LPG
$1.96B
$2K ﹤0.01%
260
-1,936
-88% -$15.4K
MIDD icon
3283
Middleby
MIDD
$6.08B
$2K ﹤0.01%
15
+5
+50% +$672
MOD icon
3284
Modine Manufacturing
MOD
$10.4B
$2K ﹤0.01%
133
-9,309
-99% -$133K
MPAA icon
3285
Motorcar Parts of America
MPAA
$258M
$2K ﹤0.01%
98
-1,876
-95% -$36.4K
MPX
3286
DELISTED
Marine Products Corp
MPX
$2K ﹤0.01%
123
-105
-46% -$1.55K
MREO
3287
Mereo BioPharma
MREO
$47.3M
$2K ﹤0.01%
+793
New +$3.47K
NICE icon
3288
Nice
NICE
$5.97B
$2K ﹤0.01%
+16
New +$2.16K
NTNX icon
3289
Nutanix
NTNX
$16.9B
$2K ﹤0.01%
78
-10,131
-99% -$353K
OCCI
3290
OFS Credit Co
OCCI
$74.9M
$2K ﹤0.01%
+136
New +$2.23K
OKTA icon
3291
Okta
OKTA
$25.8B
$2K ﹤0.01%
16
-249
-94% -$27K
OSS icon
3292
One Stop Systems
OSS
$330M
$2K ﹤0.01%
1,338
+838
+168% +$1.76K
OVLY icon
3293
Oak Valley Bancorp
OVLY
$281M
$2K ﹤0.01%
+103
New +$1.98K
PAA icon
3294
Plains All American Pipeline
PAA
$16.1B
$2K ﹤0.01%
100
-583
-85% -$13.9K
PFX icon
3295
PhenixFIN
PFX
$90M
$2K ﹤0.01%
53
-505
-91% -$29.5K
PHYS icon
3296
Sprott Physical Gold
PHYS
$15.7B
$2K ﹤0.01%
200
PJP icon
3297
Invesco Pharmaceuticals ETF
PJP
$479M
$2K ﹤0.01%
30
-28,059
-100% -$1.72M
PPC icon
3298
Pilgrim's Pride
PPC
$6.54B
$2K ﹤0.01%
89
-909
-91% -$23.5K
PSCI icon
3299
Invesco S&P SmallCap Industrials ETF
PSCI
$196M
$2K ﹤0.01%
+31
New +$2.01K
PTN
3300
Palatin Technologies
PTN
$13.8M
$2K ﹤0.01%
1
-28
-97% -$44.1K

Similar funds

Tower Research Capital (TRC)'s Q2 2019 Portfolio in Review

As of Q2 2019, Tower Research Capital (TRC) held 4,786 positions worth $1.48B, down 9.9% from $1.65B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $190M in Q2 2019, closing 1,028 positions and reducing 1,496 holdings. Its most notable exit was JPMorgan Chase, an estimated $7.56M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 5.5% of assets, up from 4.9% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Vanguard Morningstar Total Stock Market ETF worth $7.54M.

  • Tower Research Capital (TRC)'s largest Q2 2019 buy was Vanguard Morningstar Total Stock Market ETF: 50,265 shares worth $7.54M.
  • Tower Research Capital (TRC) added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $74.4M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $105M.
  • Tower Research Capital (TRC) fully exited JPMorgan Chase in Q2 2019, selling an estimated $7.56M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $1.48B portfolio in Q2 2019.
  • Tower Research Capital (TRC) opened 885 new positions and closed 1,028 in Q2 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 9.9% quarter-over-quarter to $1.48B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.